Cited by 224Psychedelics and Drug StudiesParanormal Experiences and BeliefsPain Management and Placebo Effect

Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects

Open access
Aday, Jacob S., Davis, Alan K., Mitzkovitz, Cayla M., Bloesch, Emily K., Davoli, Christopher C.·2021·ACS Pharmacology & Translational Science

Abstract

Psychedelic drugs are increasingly being incorporated into therapeutic contexts for the purposes of promoting mental health. However, they can also induce adverse reactions in some individuals, and it is difficult to predict before treatment who is likely to experience positive or adverse acute effects. Although consideration of setting and dosage as well as excluding individuals with psychotic predispositions has thus far led to a high degree of safety, it is imperative that researchers develop a more nuanced understanding of how to predict individual reactions. To this end, the current systematic review coalesced the results of 14 studies that included baseline states or traits predictive of the acute effects of psychedelics. Individuals high in the traits of absorption, openness, and acceptance as well as a state of surrender were more likely to have positive and mystical-type experiences, whereas those low in openness and surrender or in preoccupied, apprehensive, or confused psychological states were more likely to experience acute adverse reactions. Participant sex was not a robust predictor of drug effects, but 5-HT2AR binding potential, executive network node diversity, and rACC volume may be potential baseline biomarkers related to acute reactions. Finally, increased age and experience with psychedelics were individual differences related to generally less intense effects, indicating that users may become slightly less sensitive to the effects of the drugs after repeated usage. Although future well-powered, placebo-controlled trials directly comparing the relative importance of these predictors is needed, this review synthesizes the field’s current understanding of how to predict acute reactions to psychedelic drugs.

Integrity signals

Registry

Crossref · 10.1021/acsptsci.1c00014

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Patients who exhibit apprehension, preoccupation, or baseline attachment avoidance appear to be more likely to have challenging experiences following administration of a psychedelic drug.

    “patients who exhibit apprehension, preoccupation, or baseline attachment avoidance appear to be more likely to have challenging experiences following administration of a psychedelic drug”
  • Previous research suggested a general trend toward reduced psychedelic drug effects with advancing age.

    “To our knowledge, this is the first report of a relationship between age and psychedelic-induced ego dissolution, but previous research suggested a general trend toward reduced psychedelic drug effects (Aday et al., 2021) or fewer impairments of control and cognition with advancing age (Studerus et al., 2012).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Aday, J. S., Davis, A. K., Mitzkovitz, C. M., Bloesch, E. K., & Davoli, C. C.
Affiliations
  • Central Michigan University (US)
  • Johns Hopkins University (US)
Corresponding author
Aday, Jacob S.
Venue
ACS Pharmacology & Translational Science
Published
2021-03-05
Volume
4
Issue
2
Pages
424-435
ISSN
2575-9108 (ISSN-L)
OpenAlex
W3134897339
Cited by
224
References
78
Citations by year
2026: 32 · 2025: 46 · 2024: 58 · 2023: 42 · 2022: 32 · 2021: 14
FWCI
4.85
Type
journal article
Language
en
Open access
Locations
  • ACS Pharmacology & Translational Science (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • the?Steven?and Alexandra Cohen Foundation
  • Blake Mycoskie
  • Craig?Nerenberg
  • Matt Mullenweg
  • Tim Ferriss
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
Keywords
psychedelics, acute drug effects, adverse drug reactions, mystical experience, personality traits, absorption, openness to experience, acceptance, psychological state, surrender, executive network, biomarkers, individual differences, psychedelic experience

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review